These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1874265)

  • 1. Agranulocytosis associated with aprindine and other antiarrhythmic drugs: an epidemiological approach.
    Ibáñez L; Juan J; Pérez E; Carné X; Laporte JR
    Eur Heart J; 1991 May; 12(5):639-41. PubMed ID: 1874265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agranulocytosis associated with aprindine therapy.
    Bodenheimer HC; Samarel AM
    Arch Intern Med; 1979 Oct; 139(10):1181-2. PubMed ID: 485754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of aprindine induced agranulocytosis: direct toxicity on CFU-C and CFU-GEMM.
    Boogaerts MA; Peters M; Peersman C; Kesteloot H; Verwilghen RL
    Scand J Haematol; 1984 Feb; 32(2):175-8. PubMed ID: 6701462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aprindine-induced agranulocytosis. Evidence for immunologic mechanism.
    Pisciotta AV; Cronkite C
    Arch Intern Med; 1983 Feb; 143(2):241-3. PubMed ID: 6401987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Agranulocytosis during use of aprindine].
    van Leeuwen R
    Ned Tijdschr Geneeskd; 1976 Sep; 120(36):1549-50. PubMed ID: 967294
    [No Abstract]   [Full Text] [Related]  

  • 6. [Agranulocytosis and aprindine].
    Colombat P; Binet C; Reisenleiter M; Lamagnere JP
    Therapie; 1984; 39(6):718-9. PubMed ID: 6531746
    [No Abstract]   [Full Text] [Related]  

  • 7. Agranulocytosis and aprindine.
    van Leeuwen R; Meyboom RH
    Lancet; 1976 Nov; 2(7995):1137. PubMed ID: 62971
    [No Abstract]   [Full Text] [Related]  

  • 8. [Agranulocytosis caused by aprindine. Apropos of a new case].
    González Juanatey JR; Amaro Cendon A; Pose Reino A; Torre Carballada A; Rubio Alvarez J; Gil de la Peña M
    Med Clin (Barc); 1984 May; 82(19):865-6. PubMed ID: 6738221
    [No Abstract]   [Full Text] [Related]  

  • 9. [Agranulocytosis after use of aprindine (Fiboran)].
    Poortermans JC; Majid PA; Roos JP
    Ned Tijdschr Geneeskd; 1976 Nov; 120(46):2011-2. PubMed ID: 1012364
    [No Abstract]   [Full Text] [Related]  

  • 10. [Agranulocytosis and aprindine].
    Rouveix B; Lassoued K; Abel L; Regnier B
    Therapie; 1986; 41(6):517-8. PubMed ID: 3810547
    [No Abstract]   [Full Text] [Related]  

  • 11. Aprindine therapy for refractory ventricular tachycardia.
    Khan AH; Carleton RA; Chown M
    Arch Intern Med; 1983 Feb; 143(2):229-32. PubMed ID: 6824389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fatal agranulocytosis induced by aprindine].
    García Saavedra V; Peró Silva A; Llorente A; Richart C
    Rev Clin Esp; 1989; 185(3):169. PubMed ID: 2623233
    [No Abstract]   [Full Text] [Related]  

  • 13. [Agranulocytosis induced by aprindine. Pathogenetic considerations].
    Munar Qués M; Antich Rojas JL; Vich Martorell CL; Lluch Alamar DM
    Med Clin (Barc); 1985 Oct; 85(13):558-9. PubMed ID: 4079525
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fatal course of agranulocytosis during antiarryhthmic aprindine therapy].
    Hausamen TU; Weber FW
    Dtsch Med Wochenschr; 1977 Oct; 102(42):1523-4. PubMed ID: 913289
    [No Abstract]   [Full Text] [Related]  

  • 15. Risks of agranulocytosis and aplastic anemia in relation to the use of cardiovascular drugs: The International Agranulocytosis and Aplastic Anemia Study.
    Kelly JP; Kaufman DW; Shapiro S
    Clin Pharmacol Ther; 1991 Mar; 49(3):330-41. PubMed ID: 1672513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprindine and agranulocytosis.
    Opie LH
    Lancet; 1980 Sep; 2(8196):689-90. PubMed ID: 6106797
    [No Abstract]   [Full Text] [Related]  

  • 17. Population-based drug-induced agranulocytosis.
    Ibáñez L; Vidal X; Ballarín E; Laporte JR
    Arch Intern Med; 2005 Apr; 165(8):869-74. PubMed ID: 15851637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is pretransplant antiarrhythmic drug therapy a risk factor?
    Konertz W; Weyand M; Deiwick M; Scheld HH
    Transplant Proc; 1992 Dec; 24(6):2677-8. PubMed ID: 1465898
    [No Abstract]   [Full Text] [Related]  

  • 19. Aprindine.
    Danilo P
    Am Heart J; 1979 Jan; 97(1):119-24. PubMed ID: 364967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Agranulocytosis after treatment with apridine].
    Baedeker W; Rastetter J
    MMW Munch Med Wochenschr; 1977 Aug; 119(32-33):1047-8. PubMed ID: 408649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.